Related Experiment Video
Updated: Jul 18, 2026
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with
Mary Halvorson1, Sue Carpenter, Kevin Kaiserman
1Division of Endocrinology and Metabolism, Childrens Hospital Los Angeles, Los Angeles, California 90027, USA. mhalvorson@chla.usc.edu
Insights
Sensor-Augmented Pump systems combine continuous glucose monitoring with insulin pumps. This technology improved glucose control and reduced blood sugar extremes in children with type 1 diabetes.
Area of Science:
- Endocrinology
- Biomedical Engineering
- Pediatric Diabetes Management
Background:
- Type 1 diabetes requires intensive management to prevent complications.
- Traditional glucose monitoring and insulin delivery methods have limitations.
- Emerging technologies aim to improve glycemic control and reduce patient burden.
Purpose of the Study:
- To evaluate the efficacy of a Sensor-Augmented Pump system in pediatric patients with type 1 diabetes.
- To assess the impact of the system on glycemic control parameters.
- To determine the system's effect on hypoglycemia and hyperglycemia events.
Main Methods:
- A short-term pilot trial was conducted.
- Pediatric subjects with type 1 diabetes were enrolled.
- The Medtronic MiniMed Sensor-Augmented Pump system was utilized.
Main Results:
- Improved mean hemoglobin A1c (HbA1c) levels were observed.
- Mean glucose levels showed significant improvement.
- Incidences of both hypoglycemia and hyperglycemia were reduced.
Conclusions:
- The Sensor-Augmented Pump system is a promising tool for pediatric type 1 diabetes management.
- Integration of continuous glucose monitoring and insulin pump therapy enhances glycemic control.
- This technology offers potential benefits in reducing glucose variability and extreme glycemic events.
Abstract:
Real-time continuous glucose monitoring and the insulin pump have been combined into the Sensor-Augmented Pump system (Medtronic MiniMed, Northridge, CA). This short-term pilot trial demonstrated that pediatric subjects with type I diabetes improved mean hemoglobin A1c (A1c) and glucose levels and reduced hypoglycemia and hyperglycemia using the Sensor-Augmented Pump system.
